Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
117
-
Total 13F shares, excl. options
-
27.2M
-
Shares change
-
+11.3M
-
Total reported value, excl. options
-
$388M
-
Value change
-
+$155M
-
Put/Call ratio
-
3.29
-
Number of buys
-
86
-
Number of sells
-
-36
-
Price
-
$14.28
Significant Holders of ImmunityBio, Inc. - COM (IBRX) as of Q2 2021
150 filings reported holding IBRX - ImmunityBio, Inc. - COM as of Q2 2021.
ImmunityBio, Inc. - COM (IBRX) has 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.2M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (5.56M shares), BlackRock Inc. (5.27M shares), STATE STREET CORP (4.19M shares), GEODE CAPITAL MANAGEMENT, LLC (1.47M shares), NORTHERN TRUST CORP (1.35M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (765K shares), ALLEN HOLDING INC /NY (688K shares), JPMORGAN CHASE & CO (623K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (492K shares), and MORGAN STANLEY (488K shares).
This table shows the top 117 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.